Aquwell Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 78.36%
- Profit Growth -3701.67%
- Ebitda -318.97%
- Net Worth -1406.23%
- Total Assets -38.52%
About Aquwell Pharma
Aquwell Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2019 (Five years and six months 21 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Ritesh Joshi, Jaishree Gupta, and Sohan Nagar serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110GJ2019PTC109089
- Company No.
109089
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Aquwell Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sohan Nagar  | Director | 15-Oct-2020 | Current |
| Ritesh Joshi | Director | 12-Jul-2019 | Current |
| Jaishree Gupta | Director | 12-Jul-2019 | Current |
Financial Performance of Aquwell Pharma.
Aquwell Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 78.36% increase. The company also saw a substantial fall in profitability, with a 3701.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1406.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aquwell Pharma?
Unlock access to Aquwell Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aqunova Pharma Private LimitedRitesh Joshi is a mutual person
Lecorps Pharma LlpRitesh Joshi is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2023 | Uco Bank | ₹2.00 M | Open |
How Many Employees Work at Aquwell Pharma?
Unlock and access historical data on people associated with Aquwell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquwell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
